News About: Pharm. Industry
M&A and consolidation on rising trend in bio industry.
Recently the company organization enlargement and the company consolidation among the same business entities showed an ongoing stance in the world bio-engineering industry led by the United States while the number and...
Choongwae's Curoxin, new quinolone anti-bacterial drug, to launch soon.
Choongwe (President: Lee Kyung-ha) announced on Dec. 13 that they may get the health registration approval for Curoxin (Balofloxacin), a new quinolone antibacterial agent from the KFDA on Dec. 17 through the Central P...
Tendency of No-Loan Management in Medical Manufacturing Companies.
No-Loan management which medical manufacturers adopt for decreasing financial risk is increasing this year.
Il-Sung sin yak, for the first time among medical manufacturing companies, in 1999,executed no-loan manageme...
'LIBRA', right use of antibiotic campaign.
"LIBRA" campaign for right use of antibiotic lead by Bayer starts nationally.
Bayer Korea held "LIBRA" proclamation ceremony nationally which is a worldwide campaign and announced the right use of antibiotics stoppin...
Prospect of 10~15% growth of medical and pharmaceutical products in 2002 year.
It is prospected that the amount of export will vastly increase in next year, expecting the export of medical supplies in domestic will pass 76 billion dollars easily.
The reason is that the enterprises enforce the e...
Samchundang medicine manufacturer repaid loan, NO loan management.Samchundang medicine manufacturer (C.E.O is Kim Sang-jo) said, " As we re-paid the whole amount of the political fund of government aid, which was loaned through financial agenc...
|
Full scale "lighting" of curing hangover of 70 billion drink market.
Curing hangover drink market has lightened full scale and is expected to come up with special sale in year-end and in the start of the next year. According to related industry, medical manufacturers such as Jong-gun D...
CRO aggressively entering into Korean markets.
Many (CRO) agencies arranging foreign clinical research works for domestic companies actively came into the market as its necessity is ever demanding now in Korea, viewing that the new drug R&D was highly assessed wit...
Free supply of Gleevec for patients on its previous treatment.
Norvatis, recently standing in tension against the government over the price of Gleevec, announced that they would supply Gleevec in a free of charge for the patients who got previous treatment with Gleevec before No...
Top products predominated health supplement foods markets.
About 1,050 billion worth of the health supplement food market seemed to be preoccupied this year by a few of leading best sellers formulated with chitosan and squalene while Glucosamine and other cholesterol lowering...
